Cargando…

Genetic Determinants of Trehalose Utilization Are Not Associated With Severe Clostridium difficile Infection Outcome

In a case–control study of patients with Clostridium difficile infection, we found no statistically significant association between the presence of trehalose utilization variants in infecting C. difficile strains and development of severe infection outcome. These results do not support trehalose uti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saund, Katie, Rao, Krishna, Young, Vincent B, Snitkin, Evan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966243/ https://www.ncbi.nlm.nih.gov/pubmed/31976356 http://dx.doi.org/10.1093/ofid/ofz548

Ejemplares similares

Outbreak of Murine Infection with Clostridium difficile Associated with the Administration of a Pre- and Perinatal Methyl Donor Diet
por: Mau, Theresa, et al.
Publicado: (2019)

Strain Variation in Clostridioides difficile Cytotoxicity Associated with Genomic Variation at Both Pathogenic and Nonpathogenic Loci
por: Saund, Katie, et al.
Publicado: (2022)

Hogwash: three methods for genome-wide association studies in bacteria
por: Saund, Katie, et al.
Publicado: (2020)

Dietary trehalose enhances virulence of epidemic Clostridium difficile
por: Collins, J., et al.
Publicado: (2018)

290. Prediction of Severe Clostridioides difficile Infection Using Isolate Genomic Variation Influenced by Patient Comorbidity Score
por: Maggioncalda, Emily C, et al.
Publicado: (2023)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?
por: LaSalvia, Mary T., et al.
Publicado: (2017)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Procalcitonin Levels Associate with Severity of Clostridium difficile Infection
por: Rao, Krishna, et al.
Publicado: (2013)

2355. The Association Between Diagnostic Testing Method and Clostridium difficile Infection Severity
por: Menon, Anitha, et al.
Publicado: (2019)

prewas: data pre-processing for more informative bacterial GWAS
por: Saund, Katie, et al.
Publicado: (2020)

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage
por: Eyre, David W., et al.
Publicado: (2019)

2236. Stool-Derived Inflammatory Mediators Serve as Biomarkers of Severity in Clostridium difficile Infection
por: Motyka, Jonathan, et al.
Publicado: (2019)

An Observational Cohort Study of Clostridium difficile Ribotype 027 and Recurrent Infection
por: Rao, Krishna, et al.
Publicado: (2018)

76. Validation of Systemic Inflammatory Mediators as Biomarkers for Severity and Adverse Outcomes in Clostridium difficile Infection
por: Dieterle, Michael G, et al.
Publicado: (2019)

Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2016)

Clostridium difficile contamination in retail meat products in Brazil
por: Pires, Renata N., et al.
Publicado: (2018)

Performance of severity of illness classification for Clostridium difficile infection to predict need-for-colectomy or inpatient death
por: Khan, Adnan, et al.
Publicado: (2014)

The Systemic Inflammatory Response to Clostridium difficile Infection
por: Rao, Krishna, et al.
Publicado: (2014)

Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection
por: Micic, Dejan, et al.
Publicado: (2015)

Clostridium difficile in faeces from healthy dogs and dogs with diarrhea
por: Wetterwik, Karl-Johan, et al.
Publicado: (2013)

ID Learning Unit: Understanding and Interpreting Testing for Clostridium difficile
por: Solomon, Daniel A., et al.
Publicado: (2014)

Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin
por: Bunnell, Kristen L., et al.
Publicado: (2017)

A search for Clostridium difficile ribotypes 027 and 078 in Brazil
por: de Almeida Monteiro, Alexandre, et al.
Publicado: (2014)

Performance of chromID Clostridium difficile Agar Compared with BBL C. difficile Selective Agar for Detection of C. difficile in Stool Specimens
por: Han, Sang Bong, et al.
Publicado: (2014)

Using Machine Learning and the Electronic Health Record to Predict Complicated Clostridium difficile Infection
por: Li, Benjamin Y, et al.
Publicado: (2019)

Laboratory Diagnosis of Clostridium difficile Infection in Korea: The First National Survey
por: Chung, Hae-Sun, et al.
Publicado: (2019)

Risk factors for Clostridium difficile infection in HIV-infected patients
por: Imlay, Hannah, et al.
Publicado: (2016)

Flux through Trehalose Synthase Flows from Trehalose to the Alpha Anomer of Maltose in Mycobacteria
por: Miah, Farzana, et al.
Publicado: (2013)

Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Leung, Victor, et al.
Publicado: (2018)

Clostridium difficile outcomes difficult to generalize
por: Nagella, Naresh, et al.
Publicado: (2013)

Homologous Recombination in Clostridioides difficile Mediates Diversification of Cell Surface Features and Transport Systems
por: Steinberg, Hannah D., et al.
Publicado: (2020)

Determining Mortality Rates Attributable to Clostridium difficile Infection
por: Hota, Susy S., et al.
Publicado: (2012)

Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
por: Britt, Nicholas S., et al.
Publicado: (2014)

Correction: Clostridium difficile outcomes difficult to generalize
por: Nagella, Naresh, et al.
Publicado: (2014)

Outcome of ICU patients with Clostridium difficile infection
por: Zahar, Jean-Ralph, et al.
Publicado: (2012)

2403. Clostridium difficile ribotypes and human microbiota differ in Taiwan and the United States with respect to diarrheal patients
por: Motyka, Jonathan, et al.
Publicado: (2019)

No Impact of Probiotics to Reduce Clostridium difficile Infection in Hospitalized Patients: A Real-world Experience
por: Box, Maggie J, et al.
Publicado: (2018)

Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection
por: Bentivegna, Enrico, et al.
Publicado: (2021)

Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
por: Shah, Nihar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ljdtd5ocn6r7edad4tpu8h57jd